Mirtazapine to reduce methamphetamine use: a randomized controlled trial - Wikidata - awgldk - TriplyDB

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

http://www.wikidata.org/entity/Q24603456

about

Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities Pharmacotherapy of amphetamine-type stimulant dependence: an update The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Pharmacological treatments for methamphetamine addiction: current status and future directions.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.HIV prevention for people who use substances: evidence-based strategies.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period Barriers to HIV Care and Treatment Among Participants in a Public Health HIV Care Relinkage Program Effects of methamphetamine on the noradrenergic activity biomarker salivary alpha-amylase.Context-dependent effects of a single administration of mirtazapine on the expression of methamphetamine-induced conditioned place preference.Pervasive Heavy Alcohol Use and Correlates of Increasing Levels of Binge Drinking among Men Who Have Sex with Men, San Francisco, 2011 Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.Clinical implications of drug abuse epidemiology Adapted personalized cognitive counseling for episodic substance-using men who have sex with men: a randomized controlled trial Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study Testing for amphetamine-type stimulant (ATS) use to ascertain validity of self-reported ATS use among young female sex workers in Cambodia.Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.Not just the needle: the state of HIV-prevention science among substance users and future directions Specific psychiatric correlates of acute care utilization among unstably housed HIV-positive adults Methamphetamine psychosis: epidemiology and management Using Bayes factors for testing hypotheses about intervention effectiveness in addictions research.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Comprehensive clinical care for men who have sex with men: an integrated approach.Using conditioned place preference to identify relapse prevention medications.Novel interventions to prevent HIV and HCV among persons who inject drugs.Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.The neurobiological mechanisms of physical exercise in methamphetamine addiction.Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.Commentary on Konstenius et al. (2014): on medication development for stimulant addiction.No evidence of subgroups found in amphetamine consumers in Iran.Methamphetamin

P2860

Q24622161-474142D6-AA0F-49D9-8BFF-8A8DBCE65EE1 Q26865313-C354EB70-6BE6-449B-9B78-9FDF6E5CE94D Q26991936-133B4BCE-07DA-44DD-9C41-775F9A2973A4 Q28236333-2F7A9AE4-A578-495C-82CA-338E726D1408 Q30235058-1B1DA4D7-EBD1-4D04-9E7B-A836872C27C9 Q30240173-A8538127-C10C-402C-BE57-02BB9C161E4F Q34021980-29237A19-5E91-4336-87FC-3C7007C02C2D Q34154119-EF55BB7E-302D-4CD3-AB3A-18DC9920BA77 Q34181746-9F7BD791-DD40-4683-9B45-C0A898DAEBE6 Q34219147-9CD69456-E1A7-44B9-B419-B9C2940FEB3D Q34602548-4DF31E19-2709-4A64-A806-CCC025263EC2 Q35540862-4E29C737-4008-481A-A83C-BC8125777C23 Q35609720-9D110BB9-1B32-4006-BE20-6223751B944E Q35747260-65963992-7F36-48A7-8FE0-18E11FC7AA68 Q35916028-5469596B-1C2E-4987-9514-C38FA3B965BA Q36036175-019D49DF-38C6-45C8-8F5E-A1BCCCAEA8C1 Q36057853-8CD2506A-5B31-4F46-BC24-EDA9B41FA6BE Q36306978-23723F11-BC29-46FB-A163-40465DB21AC2 Q36387048-8B7B442A-9066-4806-899C-4418B47A664E Q36427002-84A1B079-5080-4833-82F8-04EE20DFF829 Q36698847-493D585C-6E18-4E73-891C-E970464F58B7 Q36813501-18799B10-A0FA-46D4-9419-09A704902AC6 Q37084003-21666E40-C59B-47B7-98AE-00786C5DC7E5 Q37212457-D31FB66D-410A-46F4-BCB9-6B128CE59EAA Q37265315-2C38F7A6-1724-406C-B632-47A062106302 Q37417696-9C3C90E0-3DC6-4465-B139-DC24D0695689 Q37533880-4D71B4E5-4A1E-482D-8BBF-F79B06AA4582 Q38028184-C58AF19B-A4A2-4ABA-8249-5AA7F6428650 Q38107338-959FFCF7-1137-4569-94C4-3110408EC398 Q38318678-0E5145CF-1E92-458A-99E9-7938EC1A9D68 Q46165138-2381BDD7-3AEA-477D-9AC3-AA02DBC8E0D4 Q46964805-C08B851F-7ED9-4360-83A4-7DB432012F8F Q47268750-C22F1F71-E30F-4E90-9DCD-537C831FF8EB Q52302064-F0B5576F-2632-4E8D-B8B9-DE6A120C01B4 Q52304091-8B5D2784-72F3-4FCF-9FB2-F0C08582FB3C Q55408568-9A913748-C40D-452B-B619-13DBD615625D Q56639321-7125B584-A459-4F97-B58E-E406A743BB03

P2860

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

http://www.wikidata.org/entity/Q24603456

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@ast

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@en

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@nl

type

label

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@ast

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@en

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@nl

prefLabel

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@ast

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@en

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@nl

P1433

Q24603456-D617A279-FBEF-47EE-B880-95F63CB453C4

P1476

Q24603456-5BB223FB-8D3E-40F8-A112-71A95C238750

P2093

Q24603456-1195C10F-9BC1-40DC-AD93-EB3CF2BE149D

Q24603456-749511DA-50A0-4BD0-A3FB-D23366016F60

Q24603456-A33DA550-EAEE-4CCE-9EA1-34D836BC822D

Q24603456-A5D9CA2D-CFB1-4A65-BE5C-9F88B85D5B58

Q24603456-C4A766DC-55EF-4934-BEA4-F4AD16FED39B

Q24603456-E35704FC-BDCC-43D9-94FC-CC1A30C17A56

Q24603456-E9EBF6B8-F85E-4B07-BA71-7B92E5F0DC48

P2860

Q24603456-10DE9DC6-2AF7-4B41-88F8-EDDDF99C2BF5

Q24603456-190BE9F7-B513-4051-A55B-89EAE59AF7A0

Q24603456-24F7ECAA-FBA9-423E-B8D8-89FA1A44550B

Q24603456-31D45CDE-21B6-43D0-911D-FA17BE3C5EB9

Q24603456-384D9D19-B7EC-4B4A-81E7-D20870F7670D

Q24603456-3AF200C5-BC14-4BEB-B39B-31FCC8DDFCFB

Q24603456-3E0C476F-6BFF-4161-B443-7C6BBAD32533

Q24603456-40F86595-C760-4C15-8F67-2EEE37336CEA

Q24603456-5A3EF5FA-986C-4DC2-B4B8-7A2139012243

Q24603456-5B95162A-3750-473C-9105-11CDB7BE3FC8

P304

Q24603456-E828E636-4068-418D-B80A-90050E048D32

P31

Q24603456-C61CB18B-A36E-4937-87E2-F847182A9E36

P3181

Q24603456-18974F77-92E2-43CB-A0BB-490E7FF80B63

P356

Q24603456-F35400B5-6383-4D20-8626-19B217396D74

P407

Q24603456-879C8FC1-D3AB-4B6C-B159-21FB1FB933CE

P433

Q24603456-AF5C7192-A2F9-4553-97A9-062C7DC2A1C8

P478

Q24603456-B364BE15-6167-4EA9-901B-0627AA930C2C

P50

Q24603456-CB88BFB5-C7BF-4CFB-9C95-0258D5A3C4FF

P577

Q24603456-769B6D0C-3B6C-4163-A174-3B038852DD56

P5875

Q24603456-382D2D5B-39D9-43E8-AF51-3EA41C36A7E6

P698

Q24603456-47A7B88D-4700-445A-AE13-30F22BE23BC3

P932

Q24603456-F741AF8D-3848-4A80-A1F2-C4721A2004A6

P3181

P356

ARCHGENPSYCHIATRY.2011.124

P1433

JAMA Psychiatry

P1476

Mirtazapine to reduce methamphetamine use: a randomized controlled trial

@en

P2093

Deirdre McDermott Santos

http://www.w3.org/2001/XMLSchema#string

Glenn-Milo Santos

http://www.w3.org/2001/XMLSchema#string

Grant N Colfax

http://www.w3.org/2001/XMLSchema#string

James Gasper

http://www.w3.org/2001/XMLSchema#string

Moupali Das

http://www.w3.org/2001/XMLSchema#string

Steve Shoptaw

http://www.w3.org/2001/XMLSchema#string

Tim Matheson

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Pharmacological approaches to methamphetamine dependence: a focused review.

Revised guidelines for HIV counseling, testing, and referral.

Tolerability and safety aspects of mirtazapine.

Does mirtazapine have a more rapid onset than SSRIs?

Mirtazapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation.

A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.

Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study.

A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.

Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review.

P304

1168-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4744234

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/ARCHGENPSYCHIATRY.2011.124

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Eric Vittinghoff

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51779451

http://www.w3.org/2001/XMLSchema#string

P698

22065532

http://www.w3.org/2001/XMLSchema#string

P932

3437988

http://www.w3.org/2001/XMLSchema#string